1[2]Mitchell MF,Schottenfeld D,Tortolero-Luna G,et al. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis.Obstet Gynecol, 1998,91:626
2[3]Raymond HK,Ervin A,Joseph I,et al. Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: sensitivity, specificity ,and cost-effectiveness. Am J Obstet Gynecol, 1997,177:930
3[4]Reid R, Stanhope CR, Herschman BR, et al. Genital warts and cervical cancer Ⅳ-a colposcopic index for differentiating subclinical papillomaviral infection from cervical intraepithelial neoplasia. Am J Obstet Gynecol,1984,149 (8): 815
4New Pap Smear Technologies Promise Improved Sensitivity. 2000 by RR Inc. Http://www. cancemetwork. com /journals/ oncnews /n 9906v. htm.
5Savage EW, Chapman G. Cervical dysplasia and cancer. In: Hacker NF, Moore JG. Essentials of Obstetrics and Gynecology. 3rd ed.Philadelphia: Saunders, 1998. 645.
6Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus Guidelines for the management of woman with cervical cytological abnormalities. JAMA,2002,287 ( 16 ) :2120.
7Lipscomb G H. Abnormal Pap Smear. In : Ling FW, Duff P (eds) Obstetrics and Gynecology, Principles for Practice. Beijing: McGraw-Hil1,2001. 1096.
8Hoskins WJ, Perez CA, Young RC. Principles and practice of gynecologic oncology. 2nd ed. Philadelphia: Lippincott-Raven, 1996. 704.
9Woolf SH. Screening for cervical cancer. US Preventive Services Task Force. Guide tO dinical preventive services: report of the U S Preventive Services Task Force. 2nd ed. Baltimore: Williams & Wilkins, 1996. 105.
10Solomon D,Davey D,Kurman R,et al. The 2001 Bethesda system: terminology for reporting result of cervical cytology. JAMA, 2002, 287(16) :2114.
